泽夫拉治疗 ZVRA
$11.59 +$1.06 (+10.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $11.45 -1.21%
开盘$10.59
昨收$10.53
当日区间$10.45 – $11.63
成交量1.53M
市值$689.66M
市盈率（TTM）9.5
股息率–
财报
财报日平均波动±8.0%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+21.3%
最差反应-19.8%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±11.8% | +12.82% | 超出定价预期 |
| 2026/Q1 | 6 May 2026 | After Market | ±13.2% | -2.22% | 符合区间 |
| 2025/Q4 | 9 Mar 2026 | After Market | ±20.0% | +21.27% | 超出定价预期 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±14.0% | -9.73% | 符合区间 |
| 2025/Q2 | 12 Aug 2025 | After Market | ±16.9% | -19.81% | 超出定价预期 |
| 2025/Q1 | 13 May 2025 | After Market | ±21.7% | +3.43% | 符合区间 |
| 2024/Q4 | 11 Mar 2025 | After Market | ±17.2% | -1.86% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | After Market | ±14.1% | +1.05% | 符合区间 |
| 2024/Q2 | 13 Aug 2024 | None | ±26.6% | -0.44% | 符合区间 |
| 2024/Q1 | 8 May 2024 | Pre Market | ±33.3% | -0.29% | 符合区间 |
| 2023/Q4 | 28 Mar 2024 | After Market | ±21.7% | -11.03% | 符合区间 |
| 2023/Q3 | 7 Nov 2023 | Pre Market | ±14.3% | -3.51% | 符合区间 |
| 2023/Q2 | 14 Aug 2023 | Pre Market | ±26.3% | +3.85% | 符合区间 |
| 2023/Q1 | 15 May 2023 | Pre Market | ±29.4% | +3.07% | 符合区间 |
| 2022/Q4 | 7 Mar 2023 | Pre Market | ±26.4% | -19.44% | 符合区间 |
| 2022/Q3 | 9 Nov 2022 | After Market | – | -13.99% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$39.66M+53.3% YoY
营业利润$16.78M+236.1% YoY
净利润$8.75M-88.3% YoY
摊薄每股收益$0.14-88.4% YoY
自由现金流$16.82M+540.9% YoY
经营现金流$17.03M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率95.5%
营业利润率28.7%
净利率42.8%
净资产收益率34.8%
资产收益率20.8%
投入资本回报率27.3%
流动比率5.17
负债/资产比率28.1%
现金及投资$221.57M
总负债$870,000.00
净现金（净负债）$220.70M
自由现金流/营收24.0%
暂无评论——快来第一个聊聊 ZVRA。
登录后参与讨论。